Cargando…

Corrigendum: Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma

Detalles Bibliográficos
Autores principales:	Gao, Yixing, Liu, Bao, Feng, Lan, Sun, Binda, He, Shu, Yang, Yidong, Wu, Gang, E, Guoji, Liu, Chang, Gao, Yuqi, Zhang, Erlong, Zhu, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198888/ https://www.ncbi.nlm.nih.gov/pubmed/32411606 http://dx.doi.org/10.3389/fonc.2020.00644

Ejemplares similares

Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma
por: Gao, Yixing, et al.
Publicado: (2019)

Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma
por: Gao, Yixing, et al.
Publicado: (2019)

Nintedanib Alleviates Experimental Colitis by Inhibiting CEBPB/PCK1 and CEBPB/EFNA1 Pathways
por: Li, Hailong, et al.
Publicado: (2022)

Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib
por: Vidarsdottir, Linda, et al.
Publicado: (2020)

IL-10 Dysregulation in Acute Mountain Sickness Revealed by Transcriptome Analysis
por: Liu, Bao, et al.
Publicado: (2017)

Prospective signs of cleidocranial dysplasia in Cebpb deficiency
por: Huang, Boyen, et al.
Publicado: (2014)

CEBPB is associated with active tumor immune environment and favorable prognosis of metastatic skin cutaneous melanoma
por: Yang, Jingrun, et al.
Publicado: (2022)

ATF4/MYC Regulates MTHFD2 to Promote NSCLC Progression by Mediating Redox Homeostasis
por: Gao, Yixing, et al.
Publicado: (2022)

Microarray data analysis to identify crucial genes regulated by CEBPB in human SNB19 glioma cells
por: Du, Chenghua, et al.
Publicado: (2016)

Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021)

Transcription Factor CEBPB Inhibits the Expression of the Human HTR1A by Binding to 5′ Regulatory Region In Vitro
por: Liu, Yong-Ping, et al.
Publicado: (2019)

Changes in CEBPB expression in circulating leukocytes following eccentric elbow-flexion exercise
por: Blackwell, Jamie, et al.
Publicado: (2014)

Inhibition of CEBPB Attenuates Lupus Nephritis via Regulating Pim-1 Signaling
por: Wang, Xiaoyang, et al.
Publicado: (2022)

Transcription factor CEBPB inhibits the proliferation of osteosarcoma by regulating downstream target gene CLEC5A
por: Lu, Jianhua, et al.
Publicado: (2019)

Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis
por: Zhou, Zili, et al.
Publicado: (2022)

Targeting hypoxic tumour cells to overcome metastasis
por: Bennewith, Kevin L, et al.
Publicado: (2011)

Hypoxic Radioresistance: Can ROS Be the Key to Overcome It?
por: Wang, Hui, et al.
Publicado: (2019)

Loss of Stemness, EMT, and Supernumerary Tooth Formation in Cebpb(−/−)Runx2(+/−) Murine Incisors
por: Saito, Kazuyuki, et al.
Publicado: (2018)

Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma
por: Lee, Dae-Hee, et al.
Publicado: (2015)

HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma
por: Wang, Xiaoguang, et al.
Publicado: (2020)

G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenic trioxide to acute myeloid leukemia cells
por: Fu, Wanbin, et al.
Publicado: (2022)

HDAC inhibitors and their potential applications to glioblastoma therapy
por: Adamopoulou, Eleni, et al.
Publicado: (2013)

Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents
por: Zhou, Qing, et al.
Publicado: (2021)

PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathway
por: Liu, Min, et al.
Publicado: (2022)

HIGH-DIMENSIONAL HISTOPATHOLOGIC EVALUATION OF THE HYPOXIC MICROENVIRONMENT IN GLIOBLASTOMA
por: Mansouri, Sheila, et al.
Publicado: (2023)

MMP14 Contributes to HDAC Inhibition-Induced Radiosensitization of Glioblastoma
por: Zhou, Yuchuan, et al.
Publicado: (2021)

TET2 is recruited by CREB to promote Cebpb, Cebpa, and Pparg transcription by facilitating hydroxymethylation during adipocyte differentiation
por: Liu, Yunjia, et al.
Publicado: (2023)

Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
por: Marchini, Antonio, et al.
Publicado: (2016)

Development of Thiazolidinedione-Based HDAC6 Inhibitors to Overcome Methamphetamine Addiction
por: Sharma, Chiranjeev, et al.
Publicado: (2019)

HDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma
por: Lee, Sang Wu, et al.
Publicado: (2021)

Deficiency of RARα Suppresses Decidualization via Downregulating CEBPB Transcription in Women With Recurrent Implantation Failure
por: Huang, Caiyi, et al.
Publicado: (2022)

CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis
por: Wang, Zhengrong, et al.
Publicado: (2022)

Abnormal expression of CEBPB promotes the progression of renal cell carcinoma through regulating the generation of IL-6
por: Ren, Yaoqiang, et al.
Publicado: (2023)

Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
por: Everix, Liesbeth, et al.
Publicado: (2023)

Overcoming TRAIL Resistance for Glioblastoma Treatment
por: Deng, Longfei, et al.
Publicado: (2021)

Overcoming delivery barriers in immunotherapy for glioblastoma
por: Rui, Yuan, et al.
Publicado: (2021)

Barriers to overcoming immunotherapy resistance in glioblastoma
por: Gillette, Julia S., et al.
Publicado: (2023)

Corrigendum: Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
por: Chen, Ying, et al.
Publicado: (2021)

JUN activation modulates chromatin accessibility to drive TNFα‐induced mesenchymal transition in glioblastoma
por: Lv, Xuejiao, et al.
Publicado: (2022)

DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter
por: Shao, Keke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q95h98scaik25js5jq5mfqn49p